Pershing Square

Showing 1 posts of 1 posts found.


Valeant and Pershing take $290m hit over insider trading

January 2, 2018
Manufacturing and Production, Sales and Marketing Bill Ackman, Pershing Square, Valeant, biotech, drugs, pharma, pharmaceutical

Valeant Pharmaceuticals will be hoping it can begin 2018 as a fresh start, after a turbulent few years, to say …

Latest content